← Study Library
Cohort · 2011
Preclinicalcounts toward this tierIncreased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints
Choi HM, Lee YA, Yang HI, Yoo MC, Kim KS · International Journal of Rheumatic Diseases
Preclinicalcounts toward this tier
Synovial-fluid Tβ4 averaged 145 ± 88 ng/mL in osteoarthritis and 1,359 ± 1,685 ng/mL in rheumatoid arthritis. In rheumatoid joints it tracked MMP-9, MMP-13, VEGF, urokinase plasminogen activator, IL-6 and IL-8; in osteoarthritic joints it tracked none of them.
- Population
- Synovial fluid from patients with osteoarthritis and with rheumatoid arthritis
- Intervention
- None — observational measurement
- Comparator
- Osteoarthritis versus rheumatoid arthritis joints
- Limitations
- Cross-sectional correlation with wide variance in the RA group; cannot separate Tβ4 as a driver of erosion from Tβ4 as a marker of how inflamed the joint is.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental